semaglutide cardiovascular trial Wegovy shown to reduce risk of heart attack, stroke in major Semaglutide reduces cardiovascular events by

If the package feels warm or has been in transit for extended periods without adequate cooling, patients should contact their pharmacy to verify whether the medication remains safe to use

Serious adverse events were reported in a higher proportion of patients who received tirzepatide compared to semaglutide

[18] Lactation studies demonstrate that maternal injections modestly elevate breast-milk B12 concentrations without adverse infant outcomes, supporting compatibility with breastfeeding while underscoring the need for maternal repletion to prevent neonatal deficiency

Most patients can lose 1-2 pounds each week

Over a 12-month horizon, the slower starter who maintains consistency almost always outperforms the fast starter who quits at month two